Aging-related memory impairment: a behavior-genomics study - Memory genomics

Takeda0 个研究点目标入组 220 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•1. The subject has to sign and date a written informed consent form prior to the initiation of study procedures;
•2. The subject falls in the age-range of one the cohorts, i.e. 18-30; 40-60; 60-80;
•3. The subject has good comprehension of the Dutch language
•4. Normal memory performance

•- Suffering from uncontrolled, clinically significant neurologic disease or other abnormality which may impact the ability of the subject to participate or potentially confound the study results, which includes pregnancy and having received chemo treatment during the past year.
•- The presence of psychiatric illness including schizophrenia, depression, bipolar disorder, Attention Deficit Hyperactivity Disorder and autism;
•- Smoking more than 10 cigarettes a day.
•- Excessive drinking, i.e. >20 glasses of alcohol containing beverages a week,
•- Current use of psychoactive medication (e.g. antidepressants, antipsychotics), centrally acting beta blockers, use of recreational drugs from 2 weeks before until the end of the
•yearly testing ,
•- Any sensory or motor deficits which could reasonably be expected to affect test performance.
•- Consultation of a clinical expert for memory problems before having entered the study
•- Having received any investigational compound within 60 days prior to the Baseline
•(Screening) Visit

发起方

Takeda